Sente, Inc., recently announced the appointment of Michael York as president, chief executive officer and a member of the board of directors

Written by  

Sente, Inc., recently announced the appointment of Michael York as president, chief executive officer and a member of the board of directors. York joins Sente after more than 20 years in management and leadership positions at Amylin Pharmaceuticals; Santarus, Inc.; Amgen; and AstraZeneca.

Want to read more?

Subscribe to one of our monthly plans to continue reading this article.

Login to post comments
body { overflow-y: auto; } html, body { min-width: unset; }